SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-019266
Filing Date
2020-04-28
Accepted
2020-04-28 16:46:27
Documents
68
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 3-31-20 10-Q arvn-10q_20200331.htm 10-Q 1579406
2 EX-10.1 arvn-ex101_177.htm EX-10.1 93658
3 EX-31.1 arvn-ex311_124.htm EX-31.1 19378
4 EX-31.2 arvn-ex312_125.htm EX-31.2 19377
5 EX-32.1 arvn-ex321_122.htm EX-32.1 9491
6 EX-32.2 arvn-ex322_123.htm EX-32.2 9410
7 GRAPHIC gfir2uzozicz000001.jpg GRAPHIC 14477
  Complete submission text file 0001564590-20-019266.txt   5375508

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT arvn-20200331.xml EX-101.INS 920119
9 XBRL TAXONOMY EXTENSION SCHEMA arvn-20200331.xsd EX-101.SCH 48140
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arvn-20200331_cal.xml EX-101.CAL 42644
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arvn-20200331_def.xml EX-101.DEF 163005
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20200331_lab.xml EX-101.LAB 372860
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20200331_pre.xml EX-101.PRE 283355
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38672 | Film No.: 20825758
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences